113 related articles for article (PubMed ID: 37797381)
21. Preoperative Hematocrit (HCT) is a Novel and Simple Predictive Marker for Gastric Cancer Patients Who Underwent Radical Gastrectomy.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
Ann Surg Oncol; 2019 Nov; 26(12):4027-4036. PubMed ID: 31463693
[TBL] [Abstract][Full Text] [Related]
22. Radiomics signature for prediction of long-term survival and recurrence patterns in patients with gastric cancer after radical gastrectomy: A multicenter study.
Huang JM; Zhuang LP; Wang HG; Zhong LY; Xue SJ; Tian FX; Lin HY
Saudi J Gastroenterol; 2023; 29(1):21-30. PubMed ID: 36588364
[TBL] [Abstract][Full Text] [Related]
23. [Impact of preoperative lymphocyte to monocyte ratio on the prognosis of the elderly patients with stage II(-III( gastric cancer].
Cong X; Li S; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Oct; 19(10):1144-1148. PubMed ID: 27781252
[TBL] [Abstract][Full Text] [Related]
24. Tumor-infiltrating Neutrophils is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients With Gastric Cancer.
Zhang H; Liu H; Shen Z; Lin C; Wang X; Qin J; Qin X; Xu J; Sun Y
Ann Surg; 2018 Feb; 267(2):311-318. PubMed ID: 27763900
[TBL] [Abstract][Full Text] [Related]
25. Development and external validation of a prognostic nomogram for patients with gastric cancer after radical gastrectomy.
Hu X; Yang Z; Chen S; Xue J; Duan S; Yang L; Yang P; Peng S; Dong Y; Yuan L; He X; Bao G
Ann Transl Med; 2021 Dec; 9(23):1742. PubMed ID: 35071436
[TBL] [Abstract][Full Text] [Related]
26. Using the preoperative prognostic nutritional index as a predictive factor for non-cancer-related death in post-curative resection gastric cancer patients: a retrospective cohort study.
Takechi H; Fujikuni N; Tanabe K; Hattori M; Amano H; Noriyuki T; Nakahara M
BMC Gastroenterol; 2020 Aug; 20(1):256. PubMed ID: 32758144
[TBL] [Abstract][Full Text] [Related]
27. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study.
Yu X; Hu F; Yao Q; Li C; Zhang H; Xue Y
BMC Cancer; 2016 Jul; 16():480. PubMed ID: 27418164
[TBL] [Abstract][Full Text] [Related]
28. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
29. Prognostic nomograms for gastric carcinoma after D2 + total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression.
Li Y; Bai M; Gao Y
World J Surg Oncol; 2023 Jul; 21(1):207. PubMed ID: 37475024
[TBL] [Abstract][Full Text] [Related]
30. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
31. Perioperative Serum Scoring Systems Predict Early Recurrence and Poor Prognosis of Resectable Pancreatic Cancer.
Li S; Zhang G; Lu Y; Zhao T; Gao C; Liu W; Piao Y; Chen Y; Huang C; Chang A; Hao J
Front Oncol; 2022; 12():841819. PubMed ID: 35265528
[TBL] [Abstract][Full Text] [Related]
32. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
33. Blood parameters score predicts long-term outcomes in stage II-III gastric cancer patients.
Lin JX; Tang YH; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Li P; Zheng CH; Xie JW
World J Gastroenterol; 2019 Nov; 25(41):6258-6272. PubMed ID: 31749596
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of pre- and post-operative tumour markers for patients with gastric cancer.
Lin JP; Lin JX; Ma YB; Xie JW; Yan S; Wang JB; Lu J; Chen QY; Ma XF; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
Br J Cancer; 2020 Aug; 123(3):418-425. PubMed ID: 32451469
[TBL] [Abstract][Full Text] [Related]
35. Defining nomograms for predicting prognosis of early and late recurrence in gastric cancer patients after radical gastrectomy.
Liu C; Tao F; Lu J; Park S; An L
Medicine (Baltimore); 2023 Oct; 102(42):e35585. PubMed ID: 37861478
[TBL] [Abstract][Full Text] [Related]
36. Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort Study.
Pang H; Zhang W; Liang X; Zhang Z; Chen X; Zhao L; Liu K; Galiullin D; Yang K; Chen X; Hu J
Adv Ther; 2021 Sep; 38(9):4917-4934. PubMed ID: 34379305
[TBL] [Abstract][Full Text] [Related]
37. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer.
Lin JX; Huang YQ; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Li P; Huang CM; Zheng CH
BMC Surg; 2019 May; 19(1):53. PubMed ID: 31133008
[TBL] [Abstract][Full Text] [Related]
38. Development and validation of metabolic scoring to individually predict prognosis and monitor recurrence early in gastric cancer: A large-sample analysis.
Chen QY; Que SJ; Chen JY; Qing-Zhong ; Liu ZY; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng HL; Xie JW; Zheng CH; Li P; Huang CM
Eur J Surg Oncol; 2022 Oct; 48(10):2149-2158. PubMed ID: 35864012
[TBL] [Abstract][Full Text] [Related]
39. Comparison of CEA and CA19-9 as a predictive factor for recurrence after curative gastrectomy in gastric cancer.
Shibata C; Nakano T; Yasumoto A; Mitamura A; Sawada K; Ogawa H; Miura T; Ise I; Takami K; Yamamoto K; Katayose Y
BMC Surg; 2022 Jun; 22(1):213. PubMed ID: 35655198
[TBL] [Abstract][Full Text] [Related]
40. Survival Prediction and Adjuvant Chemotherapy Based on Tumor Marker for Stage IB Lung Adenocarcinoma.
Wang Y; Zheng D; Chen T; Zhang J; Yao F; Chen H
Ann Thorac Surg; 2020 Mar; 109(3):927-937. PubMed ID: 31614135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
